Abnormally high lipoprotein(a) levels in African-American communities from venezuela faced to other african-descending populations: Are ethnic origins related?

Revista Latinoamericana de Hipertension

Volumn 3, Issue 3, 2008, Pages 66-72

  Bermúdez, Valmore ^a,d   Arraiz, Nailet ^a   Rojas, Edward ^a   Faria, Judith ^a   Gotera, Daniela ^a   Guerra, Xavier ^a   Aparicio, Daniel ^a   Amell, Anilsa ^a   Souki, Aida ^a   Reyna, Nadia ^a   Mengual, Edgardo ^a   Medina, Mayerlim ^a   Núñez, Mariluz ^a   Seyfi, Hamid ^a   Ciszek, Ana ^a   Cano, Clímaco ^a   Sorell, Luis ^b   Velasco, Manuel ^c  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Genetics and Biotechnology Engineering Center   (Cuba)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d Urbanización Monte Bello ^*  (Venezuela)

Author keywords

Apo(a); Cardiovascular disease; Lipoprotein (a); Risk factor

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN;

AFRICAN AMERICAN; ARTICLE; COMMUNITY LIVING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; KOLMOGOROV SMIRNOV TEST; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; RANK SUM TEST; RISK FACTOR; VENEZUELA;

EID: 50849084149     PISSN: 18564550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP). National Cholesterol Education Program. Circulation 2002; 106: 3143-3421.
2. Enas A., Chacko V, Senthilkumar A, Puthumana N, Mohan V. Elevated Lipoprotein(a) - A Genetic Risk Factor for Premature Vascular Disease in People With and Without Standart Risk Factors: A review. Disease-a-Month 2006; 52: 5-50.
3. Marcovina SM. Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions. Clinical Chemistry 2003; 49(11): 1785-1796.
4. Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML. Inhibition of Plasminogen Activation by Lipoprotein(a): Critical Domains In Apolipoprotein(a) and Mechanism Of Inhibition on Fibrin and Degraded Fibrin. The Journal of Biological Chemistry 2003; 278(26): 23260-23269.
5. Lippi G, Guidi G. Lipoprotein (a): from ancestral benefit to a modern pathogen? Q J Med. 2000; 93: 75-84.
6. Ohira T, Schreiner PJ, Morrisett JD. Chambless LIE, Rosamond WD, Folsom AR. Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 2006, 37: 1407-1412.
7. Howard BV, Le NA, Belcher JD, Flack JM, Jacobs DR Jr., Lewis CE, Marcovina SM, Perkings LL. Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. Ann Epidemiol. 1994; 4(5): 341-350.
8. Heyden S. Von Eckardstein A, Schulte H, Schneider K, Asmann G. Raised lipoprotein(a) in hypercholesterolaemic black students compared to age-matched whites in North and South Carolina. Int J Epidemiol. 1994; 23(2): 301-306.
9. Byrne DJ, Jagroop IA, Montgomery HE, Thomas M, Mikhailidis DP, Milton NG, Winder AF. Lipoprotein(a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. J. Clin. Pathol. 2002; 55: 280-285.
10. Milionis HJ, Mittari V, Exarchakos G, Kalaitzidis R, Skevas AT, Elisaf MS. Lipoprotein(a) and acute-phase response in patients with vestibular neuronitis. European Journal of Clinical Investigation 2003; 33: 1045-1050.
11. Sorell L, Rojas G, Rodríguez M, Ramos C, Torres L, Torres MB. A sandwich ELISA based on anti-apo(a) and anti-apo B monoclonal antibodies for lipoprotein(a) measurement. Clinica Chimica Acta 1995; 236(1): 59-70.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
13. Carlos-Cândido AP, Ferreira S, Lima AA, Nicolato, RL, Nascimento S, Brândao P, Pereira A, Krieger JE, Nascimento-Neto RM, Lins Machado-Coelho GL. Lipoprotein(a) as a risk factor associated with ischemic heart disease: Ouro Preto Study. Atherosclerosis 2007; 191: 454-459.
14. Bermúdez V, Cabrera de Bravo M, Mengual E, Cano C, Leal E, González, Lemus M, Amell A. Lipoproteína(a) en una población urbana de Venezuela: evidencia de que su incremento por deprivación estrogénica es transitorio. Anales de Medicina Interna 2007; 24(6): 324-327.
15. Dirección Regional de Epidemiología del Estado Zulia. Anuario de Estadística de Salud Estado Zulia 2004. PUBLICACIÓN No 7 Abril, 2006.
16. Parra HJ, Luyéyé I, Bouramoué Ch, Demarquilly C, Fruchart JCh. Black-white differences in serum Lp (a). Clinica Chimica Acta 1987; 167: 27-31.
17. Sandholzer C, Haliman DM, Saha N, Sigurdsson G, Lackner C, Boerwinkle E, Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 1991; 86: 607-614.
18. Okosun IS, Dever GEA, Choi ST. Low birth weight is associated with elevated serum lipoprotein(a) in white and black American children ages 5-11 years. Public Health 2002; 116: 33-38.
19. Evans RW, Bunker CH, Ukoli FA, Kuller LH. Lipoprotein (a) distribution in a Nigerian population. Ethn Health 1997; 2(1-2): 47-58.
20. Martínez-Suárez JD. Mitos, Leyendas y Rostros sobre el culto a San Benito de Palermo en Venezuela. Colección Cuadernos Patrimonio Intangible en la Escuela No. 2-6. Editorial La Llama Violeta 2003. Maracaibo, Venezuela.
21. Zabala-Fernández WM, Borjas-Fajardo L, Fernández-Salgado E, Castillo C, Socca L, Portillo MG, Sánchez MA, Delgado W, Morales-Machin A, Layrisse Z, Pineda-Bernal L. Use of Short Tandem Repeats Loci to Study the Genetic Structure of Several Populations From Zulia State, Venezuela. American Journal of Human Biology 2005; 17(4): 451-459.
22. Martínez-Suárez JD. Gaita de Tambora. Colección Danzas Étnicas y Tradicionales No. 2. Consejo Nacional de la Cultura (CONAC) y Fundación Ajé (FUNDAJE) 1992. Maracaibo, Venezuela.
23. García Illia. Representaciones de identidad y organizaciones sociales afrovenezolanas. Estudios y Otras Prácticas Intellectuales Latino-americanas en Cultura y Poder. Caracas: Consejo Latinoamericano de Ciencias Sociales (CLACSO) y CEAP, FACES, Universidad Central de Venezuela 2002: 133-144.
24. Martínez-Suárez JD. San Benito de Palermo y sus Chimbángueles. Cuadernos: La Cultura Popular en la Escuela No. 2. Editorial La Llama Violeta y Fundación Aje (FUNDAJE) 2002. Maracaibo, Venezuela.
25. Rotimi ChN, Cooper RS, Marcovina SM, McGee D, Owoaje E, Ladipo M. Serum Distribution of Lipoprotein(a) in African Americans and Nigerians: Potential Evidence for a Genotype-Environmental Effect. Genetic Epidemiology 1997; 14: 157-168.
26. Osinubi OA, Abaelu AM, Reaveley DA. Apolipoprotein (A) Isoform Distribution and Plasma Lipoprotein(a) Levels In Nigerian Subjects With and Without Coronary Heart Disease. Jnl Medicine & Medical Sciences 1999; 1(1): 1-5.
27. Marcovina SM, Kennedy H, Bon GB, Cazzolato G, Galli C, Casiglia E, Puato M, Paulette P. Fish Intake, Independent of Apo(a) Size, Accounts for Lower Plasma Lipoprotein(a) Levels in Bantu Fishermen of Tanzania - The Lugalawa Study-. Arterioscler Thromb Vasc Biol. 1999; 19: 1250-1256.
28. Marcovina SM, Albers JJ, Jacobs DR Jr., Perkins LL, Lewis CE, Howard BV, Savage P. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and Affican Americans. The Cardia study. Arterioscler. Thromb. Vasc. Biol. 1993; 13: 1037-1045.
29. Nasiff-Hadad A, Núñez-Suárez A, Cordero-Rojas A, Simón-Carballo R, Ramos P, Meriño-Ibarra E. Concentraciones séricas de lipoproteína(a) en pacientes cubanos dislipémicos. Clin Invest Arterioscl 2003; 15(6): 233-238.